1年内TIR改善与传感器增强胰岛素泵治疗的1型糖尿病患者白蛋白尿减少相关
结果显示%TIR平均增加13.2%,UACR平均降低15%,且%TIR每增加10%与UACR降低19%独立相关,提示TIR改善与白蛋白尿减少相关。
要点
- %TIR每增加10%,UACR降低19%(95%CI 10-28,P=0.04)。
- 平均动脉压每降低10 mmHg,UACR降低31%(P<0.001)。
- HbA1c每降低10 mmol/mol,UACR降低18%(95%CI 1-30,P=0.07)。
核心结论
- 在1型糖尿病SAP治疗者中,治疗诱导的%TIR增加与白蛋白尿减少显著相关。
研究设计与样本
- 每3个月收集人体测量学、CGM数据及血尿样本。
主要发现
- %TIR平均变化为13.2%(95%CI 6.2-20.2)。
- HbA1c平均变化为-14.4 mmol/mol(95%CI -17.4至-10.5),即-1.3%(95%CI -1.6至-1.0)。
- UACR平均变化为-15%(95%CI -38至17),所有P<0.05。
- UACR随%TIR每增加10%降低19%(95%CI 10-28,P=0.04)。
- UACR随平均动脉压每降低10 mmHg降低31%(P<0.001)。
临床怎么用
- 对SAP治疗的1型糖尿病合并白蛋白尿患者,改善TIR可能有助于降低UACR。
- 管理白蛋白尿时,除血糖控制外还应关注平均动脉压的降低。
局限性
- 为纵向观察性分析,不能确立因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the association between treatment-induced change in continuous glucose monitoring (CGM) time in range (TIR) and albuminuria in persons with type 1 diabetes (T1D) treated with sensor-augmented insulin pumps (SAP). RESEARCH DESIGN AND METHODS: Twenty-six out of 55 participants with albuminuria and multiple daily injection therapy (25% females; median 51 [interquartile range 46-63] years of age; glycated hemoglobin A1c (HbA1c) 75 [68-88] mmol/mol [9.0% (8.4-10.4%)]; and urinary albumin-to-creatinine ratio (UACR) 89 [37-250] mg/g) were in a randomized controlled trial assigned to SAP therapy for 1 year. Anthropometrics, CGM data, and blood and urine samples were collected every 3 months. RESULTS: Mean change (95% CI) in percentage of TIR (%TIR) was 13.2% (6.2; 20.2), in HbA1c was -14.4 (-17.4; -10.5) mmol/mol (-1.3% [-1.6; -1.0]), and in UACR was -15% (-38; 17) (all P < 0.05). UACR decreased by 19% (10; 28) per 10% increase in %TIR (P = 0.04), 18% (1; 30) per 10 mmol/mol decrease in HbA1c (P = 0.07), and 31% per 10-mmHg decrease in mean arterial pressure (P < 0.001). CONCLUSIONS: In this longitudinal study, treatment-induced increase in %TIR was significantly associated with decrease in albuminuria in T1D.
引用
- Ranjan AG, Rosenlund SV, Hansen TW, et al. Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump-Treated Type 1 Diabetes. Diabetes Care. 2020. PMID: 32887707. doi:10.2337/dc20-0909
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。